Takeda Pharmaceutical Co Ltd ADR (TAK) — Financial Flexibility Index
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of $402.60 Billion (operating CF $360.04 Billion minus capex $42.57 Billion) represents 0% of total liabilities ($7.77 Trillion). Check how aggressively does Takeda Pharmaceutical Co Ltd ADR reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Takeda Pharmaceutical Co Ltd ADR Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. For the full cash flow conversion analysis, see Takeda Pharmaceutical Co Ltd ADR (TAK) cash conversion ratio.
Annual Financial Flexibility Index for Takeda Pharmaceutical Co Ltd ADR (2001–2025)
Year-by-year free cash flow to debt coverage for Takeda Pharmaceutical Co Ltd ADR. Explore TAK operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | $1.26 Trillion | $1.06 Trillion | $7.31 Trillion | ▲ +12.6% |
| 2024 | 0.15x | $1.20 Trillion | $716.34 Billion | $7.83 Trillion | ▼ -27.9% |
| 2023 | 0.21x | $1.61 Trillion | $977.16 Billion | $7.60 Trillion | ▲ +21.3% |
| 2022 | 0.17x | $1.31 Trillion | $1.12 Trillion | $7.49 Trillion | ▲ +8.3% |
| 2021 | 0.16x | $1.25 Trillion | $1.01 Trillion | $7.74 Trillion | ▲ +47.1% |
| 2020 | 0.11x | $887.46 Billion | $669.75 Billion | $8.09 Trillion | ▲ +106.4% |
| 2019 | 0.05x | $462.59 Billion | $328.48 Billion | $8.71 Trillion | ▼ -78.1% |
| 2018 | 0.24x | $506.12 Billion | $377.85 Billion | $2.09 Trillion | ▲ +56.2% |
| 2017 | 0.16x | $373.39 Billion | $261.36 Billion | $2.41 Trillion | ▲ +154.9% |
| 2016 | 0.06x | $110.35 Billion | $25.49 Billion | $1.81 Trillion | ▼ -56.3% |
| 2015 | 0.14x | $291.24 Billion | $182.52 Billion | $2.09 Trillion | ▲ +24.6% |
| 2014 | 0.11x | $226.85 Billion | $148.34 Billion | $2.03 Trillion | ▼ -52.0% |
| 2013 | 0.23x | $403.47 Billion | $307.71 Billion | $1.73 Trillion | ▼ -12.0% |
| 2012 | 0.26x | $398.47 Billion | $336.57 Billion | $1.51 Trillion | ▼ -61.9% |
| 2011 | 0.69x | $451.10 Billion | $326.94 Billion | $649.75 Billion | ▼ -2.3% |
| 2010 | 0.71x | $468.13 Billion | $381.17 Billion | $658.53 Billion | ▲ +37.3% |
| 2009 | 0.52x | $365.74 Billion | $326.27 Billion | $706.35 Billion | ▼ -16.1% |
| 2008 | 0.62x | $325.11 Billion | $292.50 Billion | $526.75 Billion | ▲ +58.3% |
| 2007 | 0.39x | $238.43 Billion | $209.28 Billion | $611.38 Billion | ▼ -33.3% |
| 2006 | 0.58x | $405.67 Billion | $373.57 Billion | $693.87 Billion | ▼ -8.9% |
| 2005 | 0.64x | $349.21 Billion | $295.54 Billion | $544.02 Billion | ▼ -2.5% |
| 2004 | 0.66x | $365.28 Billion | $311.12 Billion | $554.65 Billion | ▲ +9.0% |
| 2003 | 0.60x | $296.93 Billion | $263.45 Billion | $491.64 Billion | ▲ +9.9% |
| 2002 | 0.55x | $278.11 Billion | $240.59 Billion | $505.88 Billion | ▲ +14.2% |
| 2001 | 0.48x | $239.60 Billion | $212.66 Billion | $497.69 Billion | — |